Stevanato Group S.p.A. STVN · Stock Open Stevanato Group S.p.A. in new tab
Stevanato Group S.p.A. Analysis (STVN)
Is Stevanato Group S.p.A. a good investment? Stevanato Group S.p.A. (STVN) is currently trading at 16.85 USD. Market analysts have a consensus price target of 24.45 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 29.73. This valuation is generally in line with the broader market.
Earnings Schedule: Stevanato Group S.p.A. is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 0.84.
For income investors, Stevanato Group S.p.A. pays a dividend yield of 0.37%. With a payout ratio of 0%, the dividend appears sustainable.
Investor FAQ
Does Stevanato Group S.p.A. pay a dividend?
Yes, it pays an annual dividend of 0.05 USD (0.37% yield).
What asset class is Stevanato Group S.p.A.?
Stevanato Group S.p.A. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of 0.59.
Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.06 USD
|
| July 29, 2026 | 0.0629 |
| ▸2025 |
0.06 USD
|
| July 17, 2025 | 0.0620 |
| ▸2024 |
0.06 USD
|
| July 15, 2024 | 0.0580 |
| ▸2023 |
0.06 USD
|
| July 17, 2023 | 0.0580 |
| ▸2022 |
0.05 USD
|
| July 13, 2022 | 0.0540 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Stevanato Group S.p.A. | Jul 29, 2026 | Upcoming | 0.062915 USD |
Community Discussion